ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
Mediqstar, a South Korean medical AI startup, closed a pre-Series B round with Genaxis as sole investor. The capital will accelerate overseas commercialization of its tuberculosis diagnostic platform MycoScan and support R&D for colorectal cancer diagnostics.
Tap to vote and see what everyone thinks.
Summary by ByteBrief